Jump to content
RemedySpot.com

Course shows drug companies what NOT to put in writing

Rate this topic


Guest guest

Recommended Posts

" NEW YORK (Reuters) - Want to avoid those embarrassing internal

emails containing concerns that an important product may be harmful,

or documents that could attract the attention of an ambitious prosecutor?

The Medical Technology Learning Institute and Compliance-Alliance is

offering: " Dangerous Documents: Avoiding Land Mines in Your FDA

Records and Emails " - a course tailor-made for the drug industry and

medical device company executive anxious to cut down on pesky

multimillion-dollar legal settlements.

Dangerous Documents offers such helpful tips as: Instead of writing,

" We'll meet on Thursday to destroy the documents, " it's better to

say, " We'll meet on Thursday to implement our document retention policy. "

The course is the brain child of Compliance-Alliance founder

Singer, a former U.S. prosecutor who did litigation for the Food and

Drug Administration. "

<http://www.reutershealth.com/archive/2009/01/08/eline/links/20090108elin028.htm\

l>http://www.reutershealth.com/archive/2009/01/08/eline/links/20090108elin028.ht\

ml

--------------------------------------------------------

Sheri Nakken, R.N., MA, Hahnemannian Homeopath

Vaccination Information & Choice Network, Nevada City CA & Wales UK

Vaccines - http://www.wellwithin1.com/vaccine.htm

Vaccine Dangers & Homeopathy Online/email courses start in January 2009

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...